|
Cutaneous T-Cell Lymphoma
|
|
|
Cutaneous T-Cell Lymphoma Clinical Trials
- Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00002557 - Active, not recruiting
stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma
- Bexarotene and Interferon alfa in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030849 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; ...
- Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030589 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
- Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00060385 - Active, not recruiting
adult T-cell leukemia and lymphoma; Cutaneous T-Cell Lymphoma; Non-Hodgkin's Lymphoma
- An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients
ClinicalTrials.gov Identifier: NCT00127101 - Recruiting
Cutaneous T-Cell Lymphoma
- Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00053105 - Active, not recruiting
recurrent adult diffuse large cell lymphoma; recurrent grade III follicular large cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
- Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome
ClinicalTrials.gov Identifier: NCT00002479 - Completed
stage II cutaneous T-cell lymphoma; stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; stage I cutaneous T-cell lymphoma
- Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00098332 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- O(6)-benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00003613 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
- Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
ClinicalTrials.gov Identifier: NCT00060229 - Active, not recruiting
adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma
- A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00476554 - Recruiting
Cutaneous T-Cell Lymphoma (CTCL)
- Serum Protein Patterns in Participants With Mycosis Fungoides/Cutaneous T-Cell Lymphoma, Psoriasis, or Normal Skin
ClinicalTrials.gov Identifier: NCT00066664 - Recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma-2212
ClinicalTrials.gov Identifier: NCT00490776 - Recruiting
Cutaneous T-Cell Lymphoma
- Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00182637 - Recruiting
Cutaneous T-Cell Lymphoma; Mycosis Fungoides and Sezary Syndrome
- BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00061880 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- CpG 7909 in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00091208 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00425555 - Recruiting
Cutaneous T-Cell Lymphoma
- Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00419367 - Recruiting
Lymphoma, T-Cell, Cutaneous
- Depsipeptide to Treat T-Cell Lymphomas
ClinicalTrials.gov Identifier: NCT00007345 - Recruiting
Cutaneous T Cell Lymphoma; Peripheral T Cell Lymphoma
- Blood and Tissue Collection for Cutaneous Lymphoma Research
ClinicalTrials.gov Identifier: NCT00177268 - Recruiting
Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
- Aminocamptothecin in Treating Patients With T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00002635 - Completed
stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma
- A Single Agent Phase II Study of Depsipeptide (FK228) in the Treatment of Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00106431 - Recruiting
Cutaneous T-Cell Lymphoma
- Monoclonal Antibody SGN-30 in Treating Patients with Recurrent Or Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00118079 - Recruiting
recurrent cutaneous T-cell lymphoma; anaplastic large cell lymphoma
- Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Anti-Tac
ClinicalTrials.gov Identifier: NCT00001249 - Completed
Leukemia, T-Cell; Lymphoma, T-Cell, Cutaneous
- FR901228 in Treating Patients With T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00020436 - Recruiting
adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- A Study of APO866 for the Treatment of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00431912 - Recruiting
Cutaneous T-Cell Lymphoma
- LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00412997 - Recruiting
Tumors; Cutaneous T-Cell Lymphoma
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
ClinicalTrials.gov Identifier: NCT00221039 - Recruiting
Cutaneous T Cell Lymphoma; Mycosis Fungoides
- LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00161239 - Recruiting
T-Cell Lymphoma
- Clinical Trial of PXD101 in Patients With T-Cell Lymphomas
ClinicalTrials.gov Identifier: NCT00274651 - Recruiting
Cutaneous T-Cell Lymphoma; Peripheral T-Cell Lymphoma; Non-Hodgkin's Lymphoma
- Characterizing Serum Protein Patterns in Selected Skin Diseases
ClinicalTrials.gov Identifier: NCT00063167 - Recruiting
Psoriasis; Cutaneous T-Cell Lymphoma; Healthy
- Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00438802 - Recruiting
Lymphoma
- Phase I/II Study of Tac-Expressing Malignancies [Other than Adult T-Cell Leukemia (ATL)] with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA
ClinicalTrials.gov Identifier: NCT00001575 - Recruiting
Cutaneous T Cell Lymphoma; Hodgkin's Disease; Neoplasm; Non Hodgkin's Lymphoma; Peripheral T Cell Lymphoma
- Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas
ClinicalTrials.gov Identifier: NCT00080535 - Recruiting
Lymphoma; T-Cell; Cutaneous
- Origin and Course of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00075322 - Recruiting
Cutaneous T-Cell Lymphoma
- Immunization Against Tumor Cells in Sezary Syndrome
ClinicalTrials.gov Identifier: NCT00099593 - Recruiting
Cutaneous T-Cell Lymphoma; Sezary Syndrome
- ONTAK to Estimate Response in Cutaneous T-Cell Lymphoma According to CD25 Status
ClinicalTrials.gov Identifier: NCT00279396 - Active, not recruiting
Non-Hodgkin's Lymphoma
- Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00554827 - Recruiting
Relapsed or Refractory Cutaneous T-Cell Lymphoma
- Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00394693 - Recruiting
Lymphoma, B-Cell
- Gemcitabine, Carboplatin, and Dexamethasone With or Without Rituximab in Treating Patients With Relapsed or Primary Refractory Lymphoma
ClinicalTrials.gov Identifier: NCT00072514 - Completed
Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Cutaneous T-Cell Lymphoma; ...
- In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov Identifier: NCT00177190 - Completed
Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
- Depsipeptide in Treating Patients With Solid Tumors
ClinicalTrials.gov Identifier: NCT00019318 - Completed
stage III cutaneous T-cell lymphoma; stage IV cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; ...
- Clinical Trial of HuMax-CD4, a new drug to treat Advanced Stage T-Cell Lymphoma in the skin.
ClinicalTrials.gov Identifier: NCT00071084 - Completed
Cutaneous T-Cell Lymphoma
- Clinical Trial of HuMax-CD4, a new drug to treat Early Stage T-Cell Lymphoma in the skin.
ClinicalTrials.gov Identifier: NCT00071071 - Completed
Cutaneous T-Cell Lymphoma
- Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00306969 - Completed
Cutaneous T-Cell Lymphoma
- Study of ONTAK (denileukin diftitox) in Previously Treated Cutaneous T-cell Lymphoma Patients
ClinicalTrials.gov Identifier: NCT00051012 - Completed
Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Sezary Syndrome
- Study of ONTAK (denileukin diftitox) in Cutaneous T-cell Lymphoma (CTCL) Patients
ClinicalTrials.gov Identifier: NCT00050999 - Completed
Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Sezary Syndrome
- A Safety/Efficacy Study of SGN-30 (Antibody) in Patients with Refractory or Recurrent CD30+ Hematologic Malignancies
ClinicalTrials.gov Identifier: NCT00051597 - Completed
Hodgkin Disease; Lymphoma, Large-Cell; Sarcoma, Kaposi; Lymphoma, T-Cell, Cutaneous; Lymphoma, B-Cell
- Interleukin-2 in Treating Patients With Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00002687 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00255801 - Recruiting
Lymphoma
- LMB-2 Immunotoxin in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00085085 - Recruiting
Lymphoma
- Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00430053 - Recruiting
Lymphoma
- Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00506129 - Recruiting
Lymphoma
- Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
ClinicalTrials.gov Identifier: NCT00004106 - Active, not recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00501735 - Recruiting
T-Cell Lymphoma
- Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov Identifier: NCT00211198 - Completed
Lymphoma, T-Cell, Cutaneous
- MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
ClinicalTrials.gov Identifier: NCT00059995 - Active, not recruiting
recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ...
- Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome
ClinicalTrials.gov Identifier: NCT00057967 - Recruiting
Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Topical Romidepsin in Treating Patients With Stage I or Stage II Cutaneous T-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00477698 - Recruiting
Lymphoma
- CpG 7909 in Patients with Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00043420 - Completed
Lymphoma, T-Cell, Cutaneous
- 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00005982 - Completed
recurrent cutaneous T-cell lymphoma; recurrent mycosis fungoides/Sezary syndrome
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00004075 - Completed
adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ...
- Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00074087 - Recruiting
stage II mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; recurrent mycosis fungoides/Sezary syndrome; ...
- A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
ClinicalTrials.gov Identifier: NCT00038025 - Completed
Peripheral T-Cell Lymphoma; Cutaneous T-Cell Lymphoma; Chronic Lymphocytic Leukemia
- Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
ClinicalTrials.gov Identifier: NCT00002524 - Active, not recruiting
AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ...
- Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00002618 - Active, not recruiting
stage III childhood large cell lymphoma; stage IV childhood large cell lymphoma; childhood diffuse large cell lymphoma; ...
- Active Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
ClinicalTrials.gov Identifier: NCT00001512 - Active, not recruiting
B Cell Lymphoma; Follicular Lymphoma; Lymphoma
- Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00103246 - Recruiting
actinic keratosis; Cutaneous T-Cell Lymphoma; Skin Cancer
- Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00091559 - Completed
Cutaneous T-Cell Lymphoma; Sezary Syndrome; Mycosis Fungoides
- Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma
ClinicalTrials.gov Identifier: NCT00002571 - Active, not recruiting
AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ...
- Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
ClinicalTrials.gov Identifier: NCT00003388 - Active, not recruiting
AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related lymphoblastic lymphoma; ...
- VELCADE® (bortezomib) with Rituximab in Subjects with Relapsed or Refractory Indolent B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00085696 - Active, not recruiting
B-Cell Lymphoma; Follicular Lymphoma; Marginal Lymphoma
- Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00055640 - Active, not recruiting
adult diffuse large cell lymphoma; childhood diffuse large cell lymphoma; childhood large cell lymphoma
- Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00005074 - Active, not recruiting
stage I mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma; recurrent mantle cell lymphoma; ...
- Bortezomib in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030875 - Active, not recruiting
stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
- Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002481 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00020943 - Active, not recruiting
stage I mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; ...
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003957 - Active, not recruiting
recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
- Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00049439 - Active, not recruiting
AIDS-related diffuse large cell lymphoma; AIDS-related diffuse mixed cell lymphoma; AIDS-related diffuse small cleaved cell lymphoma; ...
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003215 - Active, not recruiting
adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00002941 - Active, not recruiting
recurrent childhood lymphoblastic lymphoma; childhood diffuse large cell lymphoma; childhood immunoblastic large cell lymphoma; ...
- Combination Chemotherapy in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy
ClinicalTrials.gov Identifier: NCT00002488 - Active, not recruiting
recurrent adult lymphoblastic lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
- Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00004162 - Active, not recruiting
AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related diffuse mixed cell lymphoma; ...
- Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00004907 - Completed
adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
- Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00006383 - Active, not recruiting
recurrent adult immunoblastic large cell lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent adult diffuse large cell lymphoma; ...
- BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00039156 - Active, not recruiting
recurrent grade III follicular large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult diffuse large cell lymphoma; ...
- Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003423 - Active, not recruiting
stage I childhood large cell lymphoma; stage III childhood lymphoblastic lymphoma; stage III childhood large cell lymphoma; ...
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00053092 - Active, not recruiting
contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage I mantle cell lymphoma; stage III mantle cell lymphoma; ...
- Rituximab and Cladribine in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00053027 - Active, not recruiting
contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage I mantle cell lymphoma; stage III mantle cell lymphoma; ...
- Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00005631 - Active, not recruiting
recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse large cell lymphoma; anaplastic large cell lymphoma
- Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00079261 - Active, not recruiting
adult diffuse large cell lymphoma; adult lymphomatoid granulomatosis; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; ...
- Comparison of Combination Chemotherapy Regimens in Treating Children Who Have Anaplastic Large Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00006455 - Recruiting
stage I childhood large cell lymphoma; stage II childhood large cell lymphoma; stage III childhood large cell lymphoma; ...
- Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00039351 - Active, not recruiting
stage I adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma; ...
- Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00004192 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00041132 - Active, not recruiting
stage III mantle cell lymphoma; stage IV mantle cell lymphoma; contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma
- Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00005985 - Active, not recruiting
Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma
- Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002552 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
ClinicalTrials.gov Identifier: NCT00060112 - Suspended
adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma
- Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment
ClinicalTrials.gov Identifier: NCT00014209 - Active, not recruiting
recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ...
- Pixantrone or Other Chemotherapy Drugs in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00101049 - Recruiting
adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma; ...
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
